The uptick in Zydus Life share price came after the company announced that it has received final approval from the USFDA to ...

Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multiple strengths. The ...

Typhoid is already a disease of concern globally and various endemic countries already have TCV as part of their national ...

Zydus Lifesciences Ltd on Wednesday (March 5) said it has received final approval from the United States Food and Drug ...

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture ...

Leveraging its World Health Organization (WHO)-prequalified Typhoid Conjugate Vaccine (ZyVac TCV) and a Shigella vaccine from ...

Dasatinib is the generic version of Sprycel® tablets, a medication widely used for treating Ph+, chronic myeloid leukemia ...

Zydus Lifesciences is developing a combination vaccine targeting shigellosis and typhoid, with support from the Gates ...

Pharma major, Zydus Lifesciences on Wednesday said that it has launched ANVIMO (Letermovir), a new and innovative treatment ...

Zydus Lifesciences introduces ANVIMO, a cost-effective medication for preventing CMV infection in transplant patients, ...

Traditional CMV treatments, such as ganciclovir and valganciclovir, have notable limitations, including toxicity and bone ...

Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid.